First-Year Antibiotics Exposure in Relation to Childhood Asthma, Allergies, and Airway Illnesses

Zhijun Zou1, Wei Liu2, Chen Huang1

  • 1Department of Building Environment and Energy Engineering, School of Environment and Architecture, University of Shanghai for Science and Technology, Shanghai 200093, China.

Insights

Early antibiotic exposure in the first year of life significantly increases the risk of childhood asthma, allergies, and airway illnesses like pneumonia and wheeze. These findings highlight the importance of judicious antibiotic use in infants.

Area of Science:

  • Pediatrics
  • Environmental Health
  • Epidemiology

Background:

  • The relationship between early antibiotic exposure and childhood respiratory and allergic diseases remains a subject of ongoing scientific debate.
  • Understanding these associations is crucial for public health initiatives and clinical practice guidelines.

Purpose of the Study:

  • To investigate the association between antibiotic exposure during a child's first year of life and the subsequent development of asthma, allergies, and airway illnesses.
  • To identify specific childhood health outcomes linked to early antibiotic use.

Main Methods:

  • A cross-sectional study involving 13,335 preschoolers in Shanghai, China (2011-2012).
  • Parental questionnaires collected data on household environment, lifestyle, and child health outcomes.
  • Multivariate logistic regression analysis was employed to assess the associations.

Main Results:

  • First-year antibiotic exposure was significantly associated with increased odds of lifetime pneumonia, croup, wheeze, asthma, food allergy, and allergic rhinitis.
  • Exposure also correlated with higher incidence of current common cold, dry cough, atopic dermatitis, wheeze, and rhinitis symptoms.
  • Effect modification by individual characteristics and other early life exposures was observed.

Conclusions:

  • First-year antibiotic exposure emerges as a significant risk factor for childhood pneumonia, asthma, and allergies.
  • Individual child characteristics and co-occurring early life exposures may modulate the impact of early antibiotics on allergic and airway conditions.

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.2K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.1K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
1.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.6K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.9K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.0K